This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT04913337
Brief Title: Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

First Submitted : May 20, 2021
First Submitted that Met QC Criteria : June 2, 2021
First Posted : June 4, 2021

Last Update Submitted that Met QC Criteria : February 8, 2023
Last Update Posted : February 10, 2023